STEPUPIORS joined forces with ELMUMY and MULTIR EU Project in Athens on October 3, 2024, to enravel collaborative approaches for efficient and effective utilization of funds provided by the European Research Executive Agency.

 

πŒπ”π‹π“πˆπ‘ is focused on predicting and manipulating immune responses in multiple cancer types, including melanoma, lung, and bladder cancers.

https://www.multir.eu/

 

π„π‹πŒπ”πŒπ˜ continues to focus on identifying risk factors and health determinants that lead to the progression of monoclonal gammopathies into multiple myeloma.

https://www.elmumy.eu/

 

𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐒𝐨𝐧𝐬 from all three projects showcased innovative research and solutions, and the dynamic 𝐐&𝐀 𝐬𝐞𝐬𝐬𝐒𝐨𝐧𝐬 enabled exploring the impact of potential synergistic approach.